Rachel McMinn
Overview
Rachel McMinn received an average of $2M in total compensation, including $313K in salary, at Intercept Pharmaceuticals between 2014 and 2015.
Source: SEC filing on June 20, 2016.
Related executives
We found 16 more executives who work or worked at Intercept Pharmaceuticals.
Jerome Durso
Intercept Pharmaceuticals
Chief Executive Officer
Jared Freedberg
Intercept Pharmaceuticals
General Counsel
Michelle Berrey
Intercept Pharmaceuticals
Chief Medical Officer
Gail Cawkwell
Intercept Pharmaceuticals
SVP Medical Affairs, Safety & Pharmacovigilance
Andrew Saik
Intercept Pharmaceuticals
Chief Financial Officer
Sandip Kapadia
Intercept Pharmaceuticals
Chief Financial Officer
Rocco Venezia
Intercept Pharmaceuticals
Chief Financial Officer
Mark Pruzanski
Intercept Pharmaceuticals